Lake Street Sticks to Its Buy Rating for TELA Bio (TELA)
Analysts Are Bullish on Top Healthcare Stocks: TELA Bio (TELA), Rezolute (RZLT)
Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), TELA Bio (TELA) and InfuSystem Holdings, Inc. (INFU)
TELA Bio Analyst Ratings
TELA Bio (TELA) Gets a Buy From Piper Sandler
Lake Street Reaffirms Their Buy Rating on TELA Bio (TELA)
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
JMP Securities Reiterates Market Outperform on TELA Bio, Maintains $15 Price Target
TELA Bio Analyst Ratings
Piper Sandler Initiates a Buy Rating on TELA Bio (TELA)
Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA) and Vor Biopharma (VOR)
Strategic Divestiture and Innovative Product Launch Fuel Buy Rating for TELA Bio
Lake Street Reiterates Buy on TELA Bio, Maintains $14 Price Target
TELA Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), TELA Bio (TELA) and Smith & Nephew Snats (SNN)
JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15
TELA Bio Analyst Ratings
TELA Bio (TELA) Was Upgraded to a Buy Rating at Piper Sandler
Buy Rating for TELA Bio: Resilience and Growth Potential Despite Challenges
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), TELA Bio (TELA) and Harrow Health (HROW)